General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Esperion(SIGNIFICANT), Amgen(MODEST), Medtronic(MODEST), Novartis Corporation(MODEST), Edwards(MODEST), Sanofi-Aventis(MODEST), Novo Nordisk Inc.(SIGNIFICANT), Merck & Co., Inc.(MODEST), CSL Behring (MODEST) EQUITY INTERESTS/STOCK OPTIONS: Epirium Bio(SIGNIFICANT)

View Full Disclosure